Nicolin Bloch

Person

Ossining, NY, US

People

Patents Grantslast 30 patents

Information Patent Grant
Il-2 variants with reduced binding to IL-2 receptor alpha and uses...
- Patent number 12,168,681
- Issue date Dec 17, 2024
- REGENERON PHARMACEUTICALS, INC.
- Jiaxi Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
IL-2 variants with reduced binding to IL-2 receptor alpha and uses...
- Patent number 11,834,485
- Issue date Dec 5, 2023
- REGENERON PHARMACEUTICALS, INC.
- Jiaxi Wu
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
IL12 RECEPTOR AGONISTS AND METHODS OF USE THEREOF
- Publication number 20250066441
- Publication date Feb 27, 2025
- Regeneron Pharmaceuticals, Inc.
- Aaron CHANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INDUCED NK CELLS RESPONSIVE TO CD3/TAA BISPECIFIC ANTIBODIES
- Publication number 20240277844
- Publication date Aug 22, 2024
- Regeneron Pharmaceuticals, Inc.
- Nicolin Bloch
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
INTERFERON RECEPTOR AGONISTS AND USES THEREOF
- Publication number 20240101633
- Publication date Mar 28, 2024
- Regeneron Pharmaceuticals, Inc.
- Eva-Maria WEICK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IL-2 VARIANTS WITH REDUCED BINDING TO IL-2 RECEPTOR ALPHA AND USES...
- Publication number 20240067690
- Publication date Feb 29, 2024
- Regeneron Pharmaceuticals, Inc.
- Jiaxi Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INTERFERON RECEPTOR AGONISTS AND USES THEREOF
- Publication number 20240067691
- Publication date Feb 29, 2024
- Regeneron Pharmaceuticals, Inc.
- Eva-Maria WEICK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INTERLEUKIN-2 PROPROTEINS AND USES THEREOF
- Publication number 20230391844
- Publication date Dec 7, 2023
- Regeneron Pharmaceuticals, Inc.
- Jiaxi WU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL27 RECEPTOR AGONISTS AND METHODS OF USE THEREOF
- Publication number 20230110958
- Publication date Apr 13, 2023
- Regeneron Pharmaceuticals, Inc.
- Arielle Glatman Zaretsky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL12 RECEPTOR AGONISTS AND METHODS OF USE THEREOF
- Publication number 20230051304
- Publication date Feb 16, 2023
- Regeneron Pharmaceuticals, Inc.
- Aaron CHANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL2-BASED THERAPEUTICS AND METHODS OF USE THEREOF
- Publication number 20220402989
- Publication date Dec 22, 2022
- Regeneron Pharmaceuticals, Inc.
- Jiaxi Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL-2 VARIANTS WITH REDUCED BINDING TO IL-2 RECEPTOR ALPHA AND USES...
- Publication number 20210324030
- Publication date Oct 21, 2021
- Regeneron Pharmaceuticals, Inc.
- Jiaxi Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Nicolin Bloch

Person

Patents Grantslast 30 patents

Il-2 variants with reduced binding to IL-2 receptor alpha and uses...

IL-2 variants with reduced binding to IL-2 receptor alpha and uses...

Patents Applicationslast 30 patents

IL12 RECEPTOR AGONISTS AND METHODS OF USE THEREOF

INDUCED NK CELLS RESPONSIVE TO CD3/TAA BISPECIFIC ANTIBODIES

INTERFERON RECEPTOR AGONISTS AND USES THEREOF

IL-2 VARIANTS WITH REDUCED BINDING TO IL-2 RECEPTOR ALPHA AND USES...

INTERFERON RECEPTOR AGONISTS AND USES THEREOF

INTERLEUKIN-2 PROPROTEINS AND USES THEREOF

IL27 RECEPTOR AGONISTS AND METHODS OF USE THEREOF

IL12 RECEPTOR AGONISTS AND METHODS OF USE THEREOF

IL2-BASED THERAPEUTICS AND METHODS OF USE THEREOF

IL-2 VARIANTS WITH REDUCED BINDING TO IL-2 RECEPTOR ALPHA AND USES...